PARK7 and hepatocellular carcinoma: Furthermore, IGF2BP1 can promote ferroptosis resistance by stabilizing ferritin heavy chain 1 (FTH1), signal transducer and activator of transcription 3 (STAT3), and parkinsonism-associated deglycase (PARK7) mRNAs in HCC, bladder cancer, ovarian cancer, and GC, respectively.87, 88, 89, 90